You searched for esrd

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Last 12 months remove

MPR First Report remove

Your search for esrd returned 2 results

Sort Results:

Relevant Recent

SABCS 2022

Duration of Prior CDK4/6 Inhibitor Treatment Tied to PFS With Elacestrant

December 9, 2022

The duration of prior treatment with a CDK4/6 inhibitor appears to impact progression-free survival with elacestrant in ER+/HER2- metastatic breast cancer.

SABCS 2022

Camizestrant Improves PFS vs Fulvestrant in ER+/HER2- Advanced Breast Cancer

December 9, 2022

Camizestrant improved progression-free survival vs fulvestrant in postmenopausal patients with ER+, HER2- advanced breast cancer.